Mirum Pharmaceuticals (MIRM) FCF Margin (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly FCF Margin of 143.5% for Q1 2026, down 14170.0% year-over-year from N/an in Q1 2025, and down 4009.16% quarter-over-quarter from 3.67% in Q4 2025.
Mirum Pharmaceuticals (MIRM) FCF Margin (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' FCF Margin history runs 6 years deep, the most recent figure standing at 143.5% for Q1 2026.
- In Q1 2026, FCF Margin fell 14170.0% year-over-year to 143.5%; the TTM figure through Mar 2026 stood at 30.29% (down 2822.0% YoY), while the FY2025 annual figure was 10.53%, up 776.0% from the prior year.
- FCF Margin for Q1 2026 stood at 143.5%, down from 3.67% in the prior quarter.
- The five-year high for FCF Margin was 29.69% in Q3 2025, with the low at 307.7% in Q1 2022.
- The 5-year median for FCF Margin is 23.89% (2023), against an average of 55.35%.
- The sharpest annual moves came in 2022 and 2026: FCF Margin soared 93273 bps in 2022, then slumped 14170 bps in 2026.
- Mirum Pharmaceuticals' FCF Margin stood at 123.67% in 2022, then soared by 81 bps to 23.89% in 2023, then soared by 79 bps to 5.12% in 2024, then surged by 172 bps to 3.67% in 2025, then tumbled by 4009 bps to 143.5% in 2026.
- Business Quant data shows MIRM's FCF Margin at 143.5% in Q1 2026, 3.67% in Q4 2025, and 29.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | -25.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.12% |
| Mar 31, 2026 | -143.50% |
| Dec 31, 2025 | 3.67% |
| Sep 30, 2025 | 29.69% |
| Jun 30, 2025 | 9.32% |
| Mar 31, 2025 | -1.79% |
| Dec 31, 2024 | -5.12% |
| Sep 30, 2024 | 4.21% |
| Jun 30, 2024 | -5.88% |
| Mar 31, 2024 | 21.96% |
| Dec 31, 2023 | -23.89% |
| Sep 30, 2023 | -38.18% |
| Jun 30, 2023 | -46.40% |
| Mar 31, 2023 | -59.54% |
| Dec 31, 2022 | -123.67% |
| Sep 30, 2022 | -138.68% |
| Jun 30, 2022 | -115.47% |
| Mar 31, 2022 | -307.70% |
| Dec 31, 2021 | -1,056.41% |
| Sep 30, 2021 | -684.40% |